Charme Capital Partners and Miura Capital Acquire INDIBA from Magnum
February 28, 2022
Private equity firms Charme Capital Partners and Miura Capital have completed the acquisition of INDIBA, a Barcelona-based developer of 448 kHz radio-frequency medical devices for physiotherapy, aesthetics and veterinary markets, from Magnum. The deal positions INDIBA for a next phase of growth, with plans to expand market reach, product portfolio and operations under the new ownership.
- Buyers
- Charme Capital Partners, Miura Capital
- Targets
- INDIBA
- Sellers
- Magnum Capital
- Industry
- Medical Devices
- Location
- Catalonia, Spain
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Charme Capital Partners Acquires Majority Stake in Tema Sinergie
October 27, 2022
Medical Devices
Charme Capital Partners (through its Charme IV fund) will acquire a majority stake in Tema Sinergie S.p.A., an Italian manufacturer of isolators and filling/inspection systems for nuclear medicine and biotech pharmaceutical production. The investment will support Tema Sinergie's international expansion, product innovation and growth in theragnostic and biotech segments while preserving management continuity under CEO Stefano Piancastelli.
-
Charterhouse Acquires Metrodora Education Group
December 3, 2024
Education
Charterhouse Capital Partners has agreed to acquire Metrodora, a Madrid-headquartered education group focused on healthcare and sports training, from Magnum Capital. Charterhouse will partner with Metrodora founder Jordi Roche, who will remain a significant investor, to accelerate the group's growth, consolidation and international expansion across Spain and Latin America.
-
Miura Partners Acquires HTBA (HealthTech BioActives)
November 5, 2024
Biotechnology
Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.
-
BPEA EQT Acquires Majority Stake in Indira IVF
July 28, 2023
Healthcare Services
BPEA EQT (BPEA Private Equity Fund VIII) has agreed to acquire a majority/control stake in Indira IVF, India’s largest network of fertility clinics, from TA Associates and the founding Murdia family. The investor said it will back Indira IVF’s R&D and digital capabilities while expanding the clinic network across India and into adjacent markets as part of a growth and scale strategy.
-
Charme Capital Partners Acquires 56% Stake in Animalia
July 3, 2024
Veterinary
Charme Capital Partners (via its Charme IV fund) has agreed to take a 56% stake in Animalia through a capital increase, partnering with founders Antonino Santalucia and Giorgio Romani who will remain co-CEOs and minority shareholders. The investment will fund Animalia's consolidation and organic growth plan—including targeted add‑ons and expansion of clinic services—across its network of more than 75 clinics in Italy.
-
Avista Capital Partners Acquires Terrats Medical from Miura Partners
February 16, 2024
Healthcare Services
Avista Capital Partners has acquired Terrats Medical, a Barcelona-based manufacturer of dental prosthetics and implants, from Miura Partners. Terrats' founders and Miura have reinvested and will remain involved while Avista will support the company's international expansion, product development and inorganic growth initiatives; Terrats has more than 120 employees and exports account for over 95% of revenue.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.